Prof. Armin Gerger provides the highlights on cancers of the liver, small intestine and pancreas tract from ESMO 2016
Cancer of the Liver, Small Intestine and Pancreas tract by Prof. Armin Gerger
Prof. Armin Gerger provides the highlights on cancers of the liver, small intestine and pancreas tract from ESMO 2016
Cancer of the Liver, Small Intestine and Pancreas tract by Prof. Armin Gerger
Since 2012 Dr Armin Gerger is professor at the Medial University in Graz, Austria. He works as a clinical oncologist and coordinates the Subcentre for Gastrointestinal Neoplasia at the Comprehensive Cancer Centre, Graz. He leads the Pharmacogenetics Research Unit, at the Division of Clinical Oncology of the Medical University of Graz, and the Area “Cancer” of the Centre for Biomarker Research in Medicine (CBmed). Dr Gerger’s research focuses on prognostic and predictive genetic biomarkers in gastrointestinal cancer, which he developed further as a research fellow at the Norris Comprehensive Cancer Centre of the University of Southern California. Dr Gerger’s research activity is mirrored in several papers in high-ranked scientific journals and significant extramural funding.
Two emerging and two established targets
Announcing the publication of survey results
An expert overview of the EMERALD subgroup analysis
Managing patients with nccRCC: guidelines, recommendations, and best practice
Risk factors, diagnostic tools and treatment options for different patient groups
Exploring emerging treatment strategies presented at SABCS 2024